|
 |
|
 |
Richard Baer, Ph.D., Columbia University Medical Center
Title of Project: Which functions of BRCA1 suppress breast cancer |
|
|
 |
Mark E. Burkard, M.D., Ph.D., University of Wisconsin-Madison
Title of Project: Identifying synthetic lethal approaches targeting polyploidy in human breast cancer |
|
|
 |
Ronny Drapkin, M.D., Ph.D., Dana-Farber Cancer Institute
Title of Project: Defining the role of the fallopian tube secretory Epithelial cell in the pathogenesis of serous ovarian carcinoma |
|
|
 |
Edward Gunther, M.D., The Pennsylvania State University and the Milton S. Hershey Medical Center
Title of Project: Dissecting Mammary Cell Lineage-specific Signaling Pathway Dependencies in Breast Cancer |
|
|
 |
Richard N. Kitsis, M.D., Albert Einstein College of Medicine of Yeshiva University
Title of Project: Mechanistic Role of Necrosis – not Apoptosis – in Breast Cancer |
|
|
 |
Lawrence Lum, Ph.D., UT Southwestern Medical Center
Title of Project: Targeting the cancer stem cell compartment in breast and cervical cancer using novel tankyrase inhibitors |
|
|
 |
Martin M. Matzuk, M.D., Ph.D., Baylor College of Medicine
Title of Project: Novel microRNA Therapies for Ovarian Cancer |
|
|
 |
Rita Nahta, Ph.D., Emory University
Title of Project: Growth Differentiation Factor 15, a novel mediator of trastuzumab resistance in HER2-overexpressing breast cancer |
|
|
 |
Roel Nusse, Ph.D., Stanford University
Title of Project: Genes for self-renewal of normal and tumor breast stem cells |
|
|
 |
Sandra Ryeom, Ph.D., University of Pennsylvania School of Medicine
Title of Project: Role of the Platelet Angiogenic Proteome in Cervical Cancer |
|
|
 |
Frank Slack, Ph.D., Yale University
Title of Project: A microRNA binding site mutation in KRAS and risk of hereditary breast and ovarian cancer |
|
|
 |
Elizabeth Swisher, M.D., University of Washington
Title of Project: BRCA1/2 Restoration as a Predictor in a GOG Clinical Trial for Recurrent Ovarian Carcinoma |
|
|
 |
Angelique W. Whitehurst, Ph.D., The University of North Carolina at Chapel Hill
Title of Project: Defining a Functional Signature of Chemosensitivity in Ovarian Cancer Subtypes |
|
|
|
|